Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

January 26, 2023 

    • Tags:

As R&D efforts in the microbiome therapeutics sector continue to intensify, List Labs in investing early to build upon its existing live biotherapeutic product (LBP) manufacturing capabilities, solidifying a position as a leading contract development and manufacturing organization (CDMO) in the field of microbiome-based therapies.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: